Ardelyx (ARDX) Amortization of Deferred Charges (2015 - 2022)
Ardelyx (ARDX) reported Amortization of Deferred Charges of $179000.0 for Q2 2022, up 163.24% on a YoY basis from $68000.0 in Q2 2021, and up 280.85% quarter-over-quarter from $47000.0 in Q1 2022.
Ardelyx (ARDX) Amortization of Deferred Charges (2015 - 2022) Analysis & Trends
Ardelyx has reported Amortization of Deferred Charges for 8 years, with the latest figure at $179000.0 in Q2 2022.
- For the quarter ending Q2 2022, Amortization of Deferred Charges rose 163.24% year-over-year to $179000.0; the trailing twelve-month figure through Jun 2022 stood at $321000.0 (down 10.58% YoY), and the FY2021 full-year result was $240000.0, down 51.61% from the prior year.
- Amortization of Deferred Charges for Q2 2022 stood at $179000.0, up from $47000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $396000.0 in Q3 2019, with the low at -$241000.0 in Q4 2019.
- Historically, Amortization of Deferred Charges has averaged $83722.2 across 5 years, with a median of $77500.0 in 2019.
- Annual changes were most pronounced in 2019 — Amortization of Deferred Charges plunged 361.96% — and 2021, when it soared 806.38%.
- Ardelyx's Amortization of Deferred Charges stood at $92000.0 in 2018, then sank by 361.96% to -$241000.0 in 2019, then soared by 208.3% to $261000.0 in 2020, then plunged by 190.8% to -$237000.0 in 2021, then surged by 175.53% to $179000.0 in 2022.
- The last three Amortization of Deferred Charges figures came in at $179000.0 (Q2 2022), $47000.0 (Q1 2022), and -$237000.0 (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | 179,000.00 |
| Jun 30, 2022 | 179,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Mar 31, 2022 | 47,000.00 |
| Dec 31, 2021 | -237,000.00 |
| Dec 31, 2021 | -237,000.00 |
| Sep 30, 2021 | 332,000.00 |
| Sep 30, 2021 | 332,000.00 |
| Jun 30, 2021 | 68,000.00 |
| Jun 30, 2021 | 68,000.00 |
| Mar 31, 2021 | 77,000.00 |
| Mar 31, 2021 | 77,000.00 |
| Dec 31, 2020 | 261,000.00 |
| Dec 31, 2020 | 261,000.00 |
| Sep 30, 2020 | -47,000.00 |
| Sep 30, 2020 | -47,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Jun 30, 2020 | 170,000.00 |
| Mar 31, 2020 | 112,000.00 |
| Mar 31, 2020 | 112,000.00 |